Clinical Trials
2 trialsNCT05637567 2023-11-13
ASAP
German Cancer Research Center
Phase 2 Not yet recruiting
NCT06018688 2023-09-21
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Not yet recruiting